- Research works
- 7 ▲ 111% vs 2013–17
- Citations
- 131 19.1 per fractional work
- Top-10% rate
- 5.4% record average 16.5%
- Open access
- 31% world 28%
Not ranked overall: Mast Cell Disease Society is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which research topics does Mast Cell Disease Society publish most on?
By volume in 2022–2025: Mast cells and histamine, Mycobacterium research and diagnosis, Immunodeficiency and Autoimmune Disorders and Orthopaedic implants and arthroplasty.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Mast cells and histamine Immunology 2 works
- 2 Mycobacterium research and diagnosis Epidemiology 0 works
- 3 Immunodeficiency and Autoimmune Disorders Immunology 0 works
- 4 Orthopaedic implants and arthroplasty Surgery 0 works
- 5 Orthopedic Infections and Treatments Surgery 0 works
- 6 Total Knee Arthroplasty Outcomes Surgery 0 works
- 7 Psoriasis: Treatment and Pathogenesis Immunology 0 works
- 8 Asthma and respiratory diseases Physiology 0 works
- 9 Veterinary Oncology Research Pulmonary and Respiratory Medicine 0 works
- 10 Sympathectomy and Hyperhidrosis Treatments Physiology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Mast Cell Disease Society's research output changed?
Output in 2018–2022 was 111% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Sterling
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.